Listen: Pharma’s telehealth gold mine, the return of the biotech IPO, & a merger deferred

STAT September 15, 2022
Damian Garde, Allison DeAngelis and Adam Feuerstein

Is online prescribing a good idea? When is $2 billion not a lot of money? And what’s going to happen at J.P. Morgan 2023?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. Our colleague Katie Palmer joins us to explain a burgeoning trend in pharmaceutical advertising that has health policy experts alarmed. We also discuss the White House’s investment in biotech, a bellwether IPO, and the latest twist in the Merck-Seagen saga.

For more on what we cover, here’s the story on...

Today's Sponsors

Today's Sponsor